CLINICAL PHARMACOKINETICS OF VALPROIC ACID - 1988

被引:181
作者
ZACCARA, G
MESSORI, A
MORONI, F
机构
[1] UNIV FLORENCE,DEPT PRECLIN & CLIN PHARMACOL,I-50134 FLORENCE,ITALY
[2] CAREGGI HOSP,PHARMACEUT SERV,FLORENCE,ITALY
关键词
D O I
10.2165/00003088-198815060-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:367 / 389
页数:23
相关论文
共 151 条
[1]   THE EFFECT OF ASPIRIN ON VALPROIC ACID METABOLISM [J].
ABBOTT, FS ;
KASSAM, J ;
ORR, JM ;
FARRELL, K .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (01) :94-100
[2]   IDENTIFICATION OF VALPROIC ACID METABOLITES IN HUMAN-SERUM AND URINE USING HEXADEUTERATED VALPROIC ACID AND GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ANALYSIS [J].
ACHEAMPONG, A ;
ABBOTT, F ;
BURTON, R .
BIOMEDICAL MASS SPECTROMETRY, 1983, 10 (11) :586-595
[3]   FREE FRACTION OF VALPROIC ACID - INVITRO TIME-DEPENDENT INCREASE AND CORRELATION WITH FREE FATTY-ACID CONCENTRATION IN HUMAN-PLASMA AND SERUM [J].
ALBANI, F ;
RIVA, R ;
PROCACCIANTI, G ;
BARUZZI, A ;
PERUCCA, E .
EPILEPSIA, 1983, 24 (01) :65-73
[4]   PHARMACOKINETICS OF ENTERIC-COATED VALPROIC ACID [J].
ALBRIGHT, PS ;
BRUNI, J ;
SURIA, D .
THERAPEUTIC DRUG MONITORING, 1984, 6 (01) :21-23
[5]   POOR CORRELATION BETWEEN SINGLE-DOSE DATA AND STEADY-STATE KINETICS FOR PHENOBARBITONE, PRIMIDONE, CARBAMAZEPINE AND SODIUM VALPROATE IN CHILDREN DURING MONOTHERAPY - POSSIBLE REASONS FOR THE LACK OF CORRELATION [J].
ARMIJO, JA ;
HERRANZ, JL ;
ARTEAGA, R ;
VALIENTE, R .
CLINICAL PHARMACOKINETICS, 1986, 11 (04) :323-335
[6]   EFFECTS OF SKF525A, PHENOBARBITAL, FASTING, AND CARNITINE ON THE ANTICONVULSANT ACTIVITY AND NEUROTOXICITY OF VALPROATE IN MICE [J].
ATER, SB ;
SWINYARD, EA ;
TOLMAN, KG ;
MADSEN, JA ;
MATSUO, F .
EPILEPSIA, 1984, 25 (05) :599-604
[7]   DRUGS IN HUMAN-MILK - CLINICAL PHARMACOKINETIC CONSIDERATIONS [J].
ATKINSON, HC ;
BEGG, EJ ;
DARLOW, BA .
CLINICAL PHARMACOKINETICS, 1988, 14 (04) :217-240
[8]   PROBLEMS IN THERAPEUTIC DRUG-MONITORING - FREE DRUG LEVEL MONITORING [J].
BARRE, J ;
DIDEY, F ;
DELION, F ;
TILLEMENT, JP .
THERAPEUTIC DRUG MONITORING, 1988, 10 (02) :133-143
[9]  
BARRE J, 1985, CLIN CHEM, V31, P60
[10]  
BAUER LA, 1982, CLIN PHARMACOL THER, V31, P741, DOI 10.1038/clpt.1982.104